Back to Search Start Over

Quality assurance of the PREOPANC trial (2012-003181-40) for preoperative radiochemotherapy in pancreatic cancer The dummy run

Authors :
E. Lens
Geertjan van Tienhoven
Astrid van der Horst
Eva Versteijne
Arjan Bel
Cornelis J. A. Punt
Casper H.J. van Eijck
Mustafa Suker
Jorrit Visser
Surgery
Source :
Strahlentherapie Und Onkologie, Strahlentherapie und Onkologie, 193(8), 630-638. Urban und Vogel
Publication Year :
2017
Publisher :
Urban und Vogel, 2017.

Abstract

Background The Dutch Pancreatic Cancer Group initiated the national, multicentre, controlled PREOPANC trial, randomising between preoperative radiochemotherapy and direct explorative laparotomy for patients with (borderline) resectable pancreatic cancer. The aim of this dummy run is to evaluate compliance with the radiotherapy protocol of this trial, and the quality of delineation and radiation plans. Methods Eleven radiation oncology departments open for accrual of patients in the PREOPANC trial were provided with all necessary information of a selected ‘dummy’ patient. Each institute was asked to delineate the target volumes, including gross tumour volume, internal gross tumour volume (iGTV), internal clinical target volume, and planning target volume. The institutions were also asked to provide a radiation treatment plan in accordance with the PREOPANC trial protocol. Results The range of the iGTV was 19.3–77.2 cm3 with a mean iGTV of 41.5 cm3 (standard deviation 14.8 cm3). Nine institutions made a treatment plan using an arc technique for treatment delivery, one an intensity modulated technique and one a 3-field conformal technique. All institutions reached the prescribed target coverage, without exceeding the organs at risk constraints. The institution with the 3‑field conformal technique was advised to use a more sophisticated technique (e. g. volumetric modulated arc therapy) to reduce the dose to the spinal cord. Conclusion All institutions showed acceptable deviations from the PREOPANC trial protocol and achieved an acceptable quality of delineation and radiation technique. All institutions were allowed to continue participation in the PREOPANC trial. Electronic supplementary material The online version of this article (doi:10.1007/s00066-017-1153-6) contains supplementary material, which is available to authorized users. Supplementary material: PREOPANC Protocol, version 11, radiotherapy part

Details

ISSN :
1439099X and 01797158
Volume :
193
Issue :
8
Database :
OpenAIRE
Journal :
Strahlentherapie und Onkologie
Accession number :
edsair.doi.dedup.....d88b4ce077caf5e59d457e10a49b7398